FDA has approved two denosumab biosimilars from the Amneal–mAbxience partnership: Boncresa, referencing Prolia for osteoporosis and related uses, and...

Eurobio Scientific will ask shareholders on January 26, 2026 to approve the replacement of its statutory auditor, Endrix Lyo,...

Rectify Pharmaceuticals has signed a strategic research and licensing agreement with Boehringer Ingelheim to develop oral small molecules that...

Pluri has expanded its 2024 manufacturing agreement with Remedy Cell, confirming full technology transfer of Remedy Cell’s proprietary, cell-free...

At an industry conference, we spoke with Yann Péoc’h, World Operations Transformation Excellence Director at Servier, about how deep...

Pacira BioSciences has joined PROBE, an IHI-funded public–private consortium aiming to redefine osteoarthritis research and care by building a...

Boehringer Ingelheim has advanced a Numab-derived multi-specific antibody for wet age-related macular degeneration into preclinical development, triggering a milestone...

Kamada has secured a two-year extension from Canadian Blood Services to supply four specialty plasma-derived products—WinRho, HepaGam, CytoGam, and...

CAMP4 Therapeutics has entered a research, collaboration, and license agreement with GSK to identify and develop antisense oligonucleotide drug...

Profound Therapeutics, a Flagship Pioneering company focused on discovering proteins within the expanded human proteome, has appointed Tom Chittenden...